Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NK1 receptor antagonist synthesized by RPR

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

Innapharma reports novel antidepressant

Dec. 19, 1996

Bayer describes new ASA derivatives

Dec. 19, 1996

Sandoz reports on tetraline derivatives for neurological disorders

Dec. 18, 1996

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Dec. 18, 1996

Novel GABA uptake inhibitors from Novo Nordisk

Dec. 18, 1996

Glycine therapy as a potential new approach to schizophrenia Rx

Dec. 17, 1996

Rizatriptan goes head-to-head with sumatriptan in migraine patients

Dec. 17, 1996

Cortex notified of broad patent covering calpain inhibitors

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...